Prostate-specific antigen and insulin-like growth factor binding protein-3 in nipple aspirate fluid are associated with breast cancer

This publication has 24 references indexed in Scilit:

• Insulin-like growth factor–binding protein-3 and breast cancer survival
  International Journal of Cancer, 1998
• Insulin-like Growth Factor-binding Protein (IGFBP-3) Predisposes Breast Cancer Cells to Programmed Cell Death in a Non-IGF-dependent Manner
  Journal of Biological Chemistry, 1997
• Influence of treatment with tamoxifen and change in tumor burden on the IGF-system in breast cancer patients
  International Journal of Cancer, 1996
• Correlation of Insulin-Like Growth Factor-Binding Protein-3 Messenger RNA With Protein Expression in Primary Breast Cancer Tissues: Detection of Higher Levels in Tumors With Poor Prognostic Features
  JNCI Journal of the National Cancer Institute, 1996
• Antiproliferative actions of insulin-like growth factor binding protein (IGFBP)-3 in human breast cancer cells
  Progress in Growth Factor Research, 1995
• Insulin‐like growth‐factor‐binding protein 3 is decreased in early‐stage operable pre‐menopausal breast cancer
  International Journal of Cancer, 1995
• Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age
  Clinical Biochemistry, 1994
• Expression of insulin‐like growth factor binding proteins in human breast cancer correlates with estrogen receptor status
  Journal of Cellular Biochemistry, 1993
• Responses of insulin-like growth factor binding protein-1 (IGFBP-1) and the IGFBP-3 complex to administration of insulin-like growth factor-I
  Acta Endocrinologica, 1993
• Insulin-like growth factors (IGFs) reduce IGF-binding protein-4 (IGFBP- 4) concentration and stimulate IGFBP-3 independently of IGF receptors in human fibroblasts and epidermal cells
  Endocrinology, 1992